Author

Andrew B Dippel

AstraZeneca (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:protein design· 1 Assay:protein structure· 1

Frequent Co-Authors

Adva MechalyiD· 1 shared Ariel TennenhouseiD· 1 shared Christopher Domalewski· 1 shared Daniel ChristiD· 1 shared Dorry X Zhao· 1 shared Gilad KaplaniD· 1 shared Isabel G ElliottiD· 1 shared Itay TalpiriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Adva MechalyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Synthetic BiologybioRxivPreprintNov 26, 2025

Energy-guided combinatorial co-optimization of antibody affinity and stability

Ariel Tennenhouse, Adva Mechaly, Tony Pham…·Sarel Jacob Fleishman

This paper introduces LAffAb, a method to co-optimize antibody affinity and stability through combinatorial mutation design, achieving significant affinity gains while maintaining developability.

2 citations

protein structureexperimental assay

𝕏 PostBluesky